Tony J. Zheng

MD/PhD Candidate
Oregon Health & Science University

Presentation(s):

• OC 03.5 - An Integrative Biology Approach to Model the Role of the Feedback Activation of FXI by Thrombin in the Tissue Factor Pathway

  Saturday, July 9, 2022
  2:00 PM – 2:15 PM

• LB 01.5 - Antiplatelet effects of inhibiting coagulation factor XI in a non-human primate model of atherosclerosis

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM

• PB0845 - P2Y receptor antagonists and tyrosine kinase inhibitors reduce oxLDL-mediated procoagulant platelet activity

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0882 - Rab GTPase Protein localization, regulation and function in platelets

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 58.4 - Ibrutinib inhibits BMX-dependent endothelial VCAM-1 expression in vitro and pro-atherosclerotic endothelial activation and platelet adhesion in vivo

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM